{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:59:19Z","timestamp":1782277159993,"version":"3.54.5"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jdcr.2024.12.009","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T19:21:08Z","timestamp":1734722468000},"page":"18-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Hidradenitis suppurativa induced by ipilimumab and nivolumab: A rare association"],"prefix":"10.1016","volume":"57","author":[{"given":"Alexander D.","family":"Woods","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Axelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2024.12.009_bib1","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.26083.1","article-title":"The most recent advances in understanding and managing hidradenitis suppurativa","volume":"9","author":"Narla","year":"2020","journal-title":"F1000Res"},{"issue":"4","key":"10.1016\/j.jdcr.2024.12.009_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/ajd.12766","article-title":"Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 2","volume":"59","author":"Vekic","year":"2018","journal-title":"Australas J Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2024.12.009_bib3","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jaad.2016.01.018","article-title":"Hidradenitis suppurativa (HS): an unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases","volume":"74","author":"Faivre","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jdcr.2024.12.009_bib4","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1111\/ijd.14585","article-title":"Paradoxical hidradenitis suppurativa to biologic agents: a case series and literature review","volume":"58","author":"Neves","year":"2019","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2024.12.009_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jdcr.2018.12.002","article-title":"Secukinumab and hidradenitis suppurativa: friends or foes?","volume":"5","author":"Marasca","year":"2019","journal-title":"JAAD Case Rep"},{"issue":"1","key":"10.1016\/j.jdcr.2024.12.009_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/dermatopathology8010007","article-title":"Anti-PD-1-induced hidradenitis suppurativa","volume":"8","author":"Maillard","year":"2021","journal-title":"Dermatopathology (Basel)"},{"issue":"3","key":"10.1016\/j.jdcr.2024.12.009_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2022.06.716","article-title":"33911 Hidradenitis suppurativa secondary to nivolumab","volume":"87","author":"Ayoubi","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jdcr.2024.12.009_bib8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jamadermatol.2018.1912","article-title":"Timing of onset of adverse cutaneous reactions associated with programmed cell death protein 1 inhibitor therapy","volume":"154","author":"Wang","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"10","key":"10.1016\/j.jdcr.2024.12.009_bib9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jamadermatol.2023.3003","article-title":"Cutaneous adverse events and cancer survival prognosis with immune checkpoint inhibitor treatment: a systematic review and meta-analysis","volume":"159","author":"Du","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jdcr.2024.12.009_bib10","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaad.2022.12.048","article-title":"Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study","volume":"88","author":"Zhang","year":"2023","journal-title":"J Am Acad Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624004934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624004934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T16:41:15Z","timestamp":1742229675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512624004934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":10,"alternative-id":["S2352512624004934"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.12.009","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidradenitis suppurativa induced by ipilimumab and nivolumab: A rare association","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}